Editor's note: Seeking Alpha is proud to welcome Adam May as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Premium. Click here to find out more »
With a recently depressed stock price in spite of strong science and major Q4 catalysts approaching, Aptose Biosciences (APTO) is a high-conviction pick through the end of 2020.
This article explores the science and competitive landscape for molecules in development by Aptose Biosciences, a biotech specializing in